ATE302603T1 - Phenylessigsäure-zusammensetzungen zur behandlung oder vorbeugung von hypercholesterolemia - Google Patents

Phenylessigsäure-zusammensetzungen zur behandlung oder vorbeugung von hypercholesterolemia

Info

Publication number
ATE302603T1
ATE302603T1 AT01870144T AT01870144T ATE302603T1 AT E302603 T1 ATE302603 T1 AT E302603T1 AT 01870144 T AT01870144 T AT 01870144T AT 01870144 T AT01870144 T AT 01870144T AT E302603 T1 ATE302603 T1 AT E302603T1
Authority
AT
Austria
Prior art keywords
treating
phenylesacetic
acid compositions
preventing hypercholesterolemia
hypercholesterolemia
Prior art date
Application number
AT01870144T
Other languages
English (en)
Inventor
Stanislaw R Burzynski
Original Assignee
Stanislaw R Burzynski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanislaw R Burzynski filed Critical Stanislaw R Burzynski
Application granted granted Critical
Publication of ATE302603T1 publication Critical patent/ATE302603T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01870144T 2000-06-26 2001-06-26 Phenylessigsäure-zusammensetzungen zur behandlung oder vorbeugung von hypercholesterolemia ATE302603T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/603,320 US6987131B1 (en) 2000-06-26 2000-06-26 Phenylacetic acid compositions for treating or preventing hypercholesterolemia

Publications (1)

Publication Number Publication Date
ATE302603T1 true ATE302603T1 (de) 2005-09-15

Family

ID=24414934

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01870144T ATE302603T1 (de) 2000-06-26 2001-06-26 Phenylessigsäure-zusammensetzungen zur behandlung oder vorbeugung von hypercholesterolemia

Country Status (5)

Country Link
US (1) US6987131B1 (de)
EP (1) EP1206936B1 (de)
AT (1) ATE302603T1 (de)
DE (1) DE60112872T2 (de)
HK (1) HK1048588A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1291015A1 (de) 2001-09-10 2003-03-12 Lunamed AG Darreichungsformen mit verlängerter Wirkstofffreisetzung
ITMI20040876A1 (it) * 2004-04-30 2004-07-30 Univ Degli Studi Milano Inibitori delle istone deacetilasi-hdac-quali agenti ipolipidemizzati per la terapia e la prevenzione dell'arteriosclerosi e malattie cardiovascolari
JP2008545139A (ja) * 2005-06-29 2008-12-11 ルールズ−ベースド メディスン，インコーポレーテッド 急性冠症候群の診断方法及び診断キット
KR100905419B1 (ko) 2008-09-11 2009-07-02 연세대학교 산학협력단 세스퀴테르펜 유도체의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470970A (en) 1981-07-02 1984-09-11 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US5153226A (en) 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
DE4200954A1 (de) 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate
GB9111426D0 (en) 1991-05-28 1991-07-17 Ici Plc Chemical compounds
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5635532A (en) 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
DE4208051A1 (de) 1992-03-13 1993-09-16 Bayer Ag Substituierte phenylessigsaeureamide
US5391575A (en) * 1994-05-04 1995-02-21 Burzynski; Stanislaw R. Method for treating neurofibromatosis
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
CN1088597C (zh) * 1999-10-26 2002-08-07 合肥永生制药有限公司 尿多酸肽组合物及其用途

Also Published As

Publication number Publication date
DE60112872D1 (de) 2005-09-29
EP1206936A3 (de) 2002-09-04
EP1206936A2 (de) 2002-05-22
EP1206936B1 (de) 2005-08-24
DE60112872T2 (de) 2006-06-14
HK1048588A1 (en) 2003-04-11
US6987131B1 (en) 2006-01-17

Similar Documents

Publication Publication Date Title
DE69818058D1 (de) Verwendung von polyallylamin-polymeren zur herstellung eines medikamentes zur behandlung von hypercholesterolemia
CY1109422T1 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
EA200401365A1 (ru) Способы лечения илеуса
BR0315417A (pt) Derivados 1-acil-pirrolidina para o tratamento de infecções virais
ATE224714T1 (de) Behandlung von tinnitus mit neuroprotektiven wirkstoffen
ATE301995T1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
SE0104248D0 (sv) Method of treatment
DE69229442D1 (de) Substituierte dibenzooxazepin-verbindungen, pharmazeutische zusammensetzungen und verfahren zur verwendung
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
DE69034226D1 (de) Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu
DE60118956D1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
ATE439833T1 (de) Pharmazeutische zubereitung enthaltend ein catechin, ascorbinsäure, prolin und lysin zur behandlung von neoplastischen krankheiten
BRPI0512951A (pt) compostos, processo para sua fabricação, composições farmacêuticas contendo os mesmos, uso e método para tratamento e/ou prevenção de doenças que são moduladas pelos agonistas de ppar(delta) e/ou ppar(alpha)
ATE246518T1 (de) Egr-1 zur herstellung eines medikamentes zur behandlung von wunden
ATE493125T1 (de) Carbamatverbindungen zur behandlung von schmerz
ATE302603T1 (de) Phenylessigsäure-zusammensetzungen zur behandlung oder vorbeugung von hypercholesterolemia
DE602004023100D1 (de) Verbindungen und verfahren zur behandlung von dyslipidemie
BRPI0510451A (pt) compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que são moduladas por agonistas de ppar(delta) e/ou de ppar(alfa) e sua utilização
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
NO20013085L (no) Fosfororganiske forbindelser og deres anvendelse
ATE406171T1 (de) Aplidine zur behandlung von multiplem myelom
BR0317425A (pt) Sal de rabeprazol, composição farmacêutica contendo o mesmo e processo para sua preparação
ATE263556T1 (de) Phenylessigsäure enthaltende zusammensetzungen zur behandlung und vorbeugung der atherosklerose und der restenose
DE60137506D1 (de) Verwendung von polysulfatierten cyclodextrinen zur behandlung von arthrose

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties